A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study
- PMID: 26315743
- DOI: 10.1016/j.jcin.2015.04.020
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study
Abstract
Objectives: This study conducted a prospective, single-arm, multicenter trial to evaluate the safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using the EkoSonic Endovascular System (EKOS, Bothell, Washington).
Background: Systemic fibrinolysis for acute pulmonary embolism (PE) reduces cardiovascular collapse but causes hemorrhagic stroke at a rate exceeding 2%.
Methods: Eligible patients had a proximal PE and a right ventricular (RV)-to-left ventricular (LV) diameter ratio ≥0.9 on chest computed tomography (CT). We included 150 patients with acute massive (n = 31) or submassive (n = 119) PE. We used 24 mg of tissue-plasminogen activator (t-PA) administered either as 1 mg/h for 24 h with a unilateral catheter or 1 mg/h/catheter for 12 h with bilateral catheters. The primary safety outcome was major bleeding within 72 h of procedure initiation. The primary efficacy outcome was the change in the chest CT-measured RV/LV diameter ratio within 48 h of procedure initiation.
Results: Mean RV/LV diameter ratio decreased from baseline to 48 h post-procedure (1.55 vs. 1.13; mean difference, -0.42; p < 0.0001). Mean pulmonary artery systolic pressure (51.4 mm Hg vs. 36.9 mm Hg; p < 0.0001) and modified Miller Index score (22.5 vs. 15.8; p < 0.0001) also decreased post-procedure. One GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries)-defined severe bleed (groin hematoma with transient hypotension) and 16 GUSTO-defined moderate bleeding events occurred in 15 patients (10%). No patient experienced intracranial hemorrhage.
Conclusions: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis decreased RV dilation, reduced pulmonary hypertension, decreased anatomic thrombus burden, and minimized intracranial hemorrhage in patients with acute massive and submassive PE. (A Prospective, Single-arm, Multi-center Trial of EkoSonic® Endovascular System and Activase for Treatment of Acute Pulmonary Embolism (PE) [SEATTLE II]; NCT01513759).
Keywords: catheter embolectomy; catheter thrombolysis; fibrinolysis; pulmonary embolism; right ventricular failure; thrombolysis.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand?JACC Cardiovasc Interv. 2015 Aug 24;8(10):1393-1395. doi: 10.1016/j.jcin.2015.06.009. JACC Cardiovasc Interv. 2015. PMID: 26315744 No abstract available.
Similar articles
-
Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in elderly patients with pulmonary embolism: A SEATTLE II sub-analysis.Vasc Med. 2017 Aug;22(4):324-330. doi: 10.1177/1358863X17693102. Epub 2017 Jun 18. Vasc Med. 2017. PMID: 28625110 Clinical Trial.
-
Predictors of Treatment Response Following Ultrasound-Facilitated Catheter-Directed Thrombolysis for Submassive and Massive Pulmonary Embolism: A SEATTLE II Substudy.Circ Cardiovasc Interv. 2020 Jun;13(6):e008747. doi: 10.1161/CIRCINTERVENTIONS.119.008747. Epub 2020 Jun 10. Circ Cardiovasc Interv. 2020. PMID: 32519884
-
Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.J Vasc Interv Radiol. 2015 Jul;26(7):1001-6. doi: 10.1016/j.jvir.2014.12.017. Epub 2015 Feb 18. J Vasc Interv Radiol. 2015. PMID: 25704224
-
Comparison of the Clinical Efficacy and Safety of Standard and Ultrasound-Assisted Thrombolysis for Pulmonary Embolism: A Systematic Review and Meta-Analysis.J Endovasc Ther. 2025 Jun;32(3):558-566. doi: 10.1177/15266028231181031. Epub 2023 Jun 8. J Endovasc Ther. 2025. PMID: 37291849
-
Catheter-Directed Thrombolysis for Pulmonary Embolism: The State of Practice.Tech Vasc Interv Radiol. 2018 Jun;21(2):78-84. doi: 10.1053/j.tvir.2018.03.003. Epub 2018 Mar 8. Tech Vasc Interv Radiol. 2018. PMID: 29784125 Review.
Cited by
-
Pulmonary Embolism in the Cancer Associated Thrombosis Landscape.J Clin Med. 2022 Sep 25;11(19):5650. doi: 10.3390/jcm11195650. J Clin Med. 2022. PMID: 36233519 Free PMC article. Review.
-
Immediate and late impact of reperfusion therapies in acute pulmonary embolism.Eur Heart J Suppl. 2019 Nov;21(Suppl I):I1-I13. doi: 10.1093/eurheartj/suz222. Epub 2019 Nov 21. Eur Heart J Suppl. 2019. PMID: 31777451 Free PMC article.
-
Catheter-directed therapy for acute pulmonary embolism: navigating gaps in the evidence.Eur Heart J Suppl. 2019 Nov;21(Suppl I):I23-I30. doi: 10.1093/eurheartj/suz224. Epub 2019 Nov 21. Eur Heart J Suppl. 2019. PMID: 31777454 Free PMC article.
-
Reproducibility of thrombus volume quantification in multicenter computed tomography pulmonary angiography studies.World J Radiol. 2018 Oct 28;10(10):124-134. doi: 10.4329/wjr.v10.i10.124. World J Radiol. 2018. PMID: 30386497 Free PMC article.
-
Pulmonary Embolism: Contemporary Medical Management and Future Perspectives.Ann Vasc Dis. 2018 Sep 25;11(3):265-276. doi: 10.3400/avd.ra.18-00054. Ann Vasc Dis. 2018. PMID: 30402174 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical